Chemo: Triple negative breast cancer refers to those cancers whose cells have tested negative for epidermal growth factor receptor 2 (HER-2), estrogen receptors , and progesterone receptors . They are aggressive requiring chemo for mets. The METRIC trial employs Glembatumumab vedotin (CDX-011) CALGB is evaluating carboplatin added to paclitaxel and adriamycin (doxorubicin) plus cyclophosphamide chemo
Answered 11/15/2014
3.5k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
7 doctors weighed in across 3 answers
5 doctors weighed in across 2 answers
7 doctors weighed in across 3 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question